[Medical Human Story - Episode 65] Despair After the All-Clear: Ji-woo’s Miraculous Recovery from Intraventricular Metastasis-3
Part II: Between Certainty and Despair
At the Diagnostic Crossroads: Between Suspicion and Certainty
The MRI results
were already pointing in a clear direction. The tumor exhibited distinct
malignant characteristics, and its location was highly unusual. However, in
medicine, 'suspicion' and 'certainty' exist in entirely different dimensions.
Especially when a treatment strategy could shift 180 degrees, one must verify
every single possibility until not a shadow of a doubt remains.
The final hurdle
we had to clear was determining whether this tumor truly originated from a
metastatic neuroblastoma. Whether this was a simple primary brain tumor or a
recurrence linked to past medical history would dictate the entire trajectory
of Ji-woo’s treatment.
Unmasking the Identity: The I-123 MIBG Scan
To find that
answer, we turned to a nuclear medicine study: the I-123 MIBG scan. MIBG is
more than just a contrast agent. It is a substance precision-engineered to
target the biological signature of neuroblastoma cells. Derived from the
sympathetic nervous system, these cells possess specific norepinephrine
receptors, which MIBG selectively binds to. In essence, this test doesn't just
look at 'shape'—it unmasks 'identity.'
While the scan
is being prepared, time flows with an agonizing slowness. Though the MRI
revealed much, no judgment can be finalized until that one definitive sentence
is rendered. Ji-woo remains on her bed, her pain not fully dulled by
analgesics, her consciousness flickering intermittently. Beside her, her
mother’s gaze never wavers from the child, even for a heartbeat. In that space,
I find myself being asked a question—not as a doctor, but as a human being:
'Does this truly mean a new beginning, and not the end?'
The Luminous Truth: A Radiant Lesion
The scan begins.
The radioisotope is administered, and after a set interval, the images are
acquired. The monitor reveals a world different from that of an MRI. It is a
map not of structure, but of function; not of form, but of activity.
At first, it is
faint. But as time passes, a specific area begins to emerge with searing
clarity. At that moment, everyone sees it at once. Inside Ji-woo’s ventricle,
the tumor site is glowing with an intensity incomparable to the surrounding
healthy brain tissue. It isn't just contrast. It is an overwhelming divergence.
The normal tissue is silent, but the lesion radiates a powerful signal as if
screaming its own existence.
I stare at the screen. I no longer entertain other possibilities. This is no coincidence. This is a pattern, a hallmark, a piece of decisive evidence. That light is, quite literally, 'the proof.' It seems to say: 'I am neuroblastoma.'
A Cruel Sentence: The Onset of Despair
In that instant,
every piece fits into place. The past history, the current symptoms, the
structural abnormalities seen on CT and MRI, and now the functional activity
confirmed before our eyes. They all align into a single line.
I exhale slowly,
organizing the heaviest sentence in my mind. It can no longer be delayed.
Ji-woo’s mother is still looking at me, her eyes a chaotic mix of the fear that
she already knows the answer and the hope that she might be wrong.
I speak carefully,
but clearly. "The results are in." A moment of silence. Then, the
words: "This tumor... appears to be a metastasis from her previous
neuroblastoma."
Her expression
freezes. It looks as if time itself has turned to ice. But I cannot stop.
"And currently... There is associated bleeding within the ventricle."
That sentence is
more than a mere explanation. It is the finality of reality. The diagnosis
converges into one: Intraventricular metastatic neuroblastoma with
hemorrhage. The name is long, but its meaning is blunt. We have
entered an irreversible stage. From this point forward, every choice will
decide the child’s survival. I look back at the screen. That glowing lesion is
no longer just an image. It is certainty—and the beginning of despair.
The Physician’s Creed: Logic Over Emotion
As a physician,
I had to find my center again. Emotions had to be pushed aside. No matter how
desperate the situation, a diagnosis must always be completed through a cold,
systematic process. In cases as grave as this, every other possibility must be
thoroughly excluded before reaching a conclusion. That is the minimum
responsibility to the patient and the very essence of medicine. Ji-woo’s images
pointed strongly in one direction, but 'strong conviction' can be the most
dangerous trap. The more experienced a doctor is, the more they must doubt that
conviction. I ran through the possible differentials in my head.
The Shadow of Doubt: Eliminating the Candidates
First, I
considered primary tumors that arise within the ventricles. A prime candidate
is a Central Neurocytoma. These typically occur near the septum pellucidum in
the lateral ventricles and can appear in younger patients. On imaging, they
show up as intraventricular masses, sometimes with calcification or cystic
changes. Based on location alone, it overlapped with Ji-woo's lesion.
But there was a decisive
difference. Central neurocytomas generally do not show MIBG uptake. They don't
produce the intense signal we saw in nuclear medicine. Furthermore, the
hemorrhagic pattern observed on MRI is uncommon for them. The high cellularity,
diffusion restriction, and bleeding in Ji-woo’s scan pushed this diagnosis
further away.
I moved to the
next possibility: Ependymoma. This is another representative intraventricular
tumor, relatively common in children. While often found in the fourth
ventricle, they can appear in the lateral ventricles. They form irregular
masses and can cause hydrocephalus by obstructing CSF flow—similar to Ji-woo’s
clinical presentation.
Yet, here too, a
clear line existed. Ependymomas do not selectively absorb MIBG. The intense
radioactive uptake could not be explained. Moreover, the combination of strong
diffusion restriction and hemorrhagic findings is not typical for them.
The Smoking Gun: A Final Verdict
I returned to
the beginning. Ji-woo’s history: High-risk neuroblastoma. This single line was
the key to interpreting everything. Neuroblastoma is a tumor prone to
metastasis, and those metastases sometimes follow unpredictable paths.
The intense MIBG
uptake was the smoking gun. Neuroblastoma cells selectively absorb this
substance; the signal was a biological ID card at the cellular level. Combined
with the MRI findings—diffusion restriction (a sign of a high-cell-count
malignant tumor), hemorrhagic changes (suggesting instability and aggression),
and the intraventricular location (a rare but reported metastatic site)—only
one conclusion remained. This was not something else.
Delivering Reality: A Sliver of Hope
I caught my
breath. The stage of listing 'possibilities' was over. Now came the stage of
delivering 'reality.' Ji-woo’s mother was watching me, a sliver of hope still
lingering in her eyes. I had to avoid denying that hope entirely while refusing
to hide the truth.
"Ji-woo’s
mother," I began, my voice as calm as possible. "The situation... is
going to be a difficult fight. The tumor is currently blocking the ventricle,
so the cerebrospinal fluid isn't flowing properly. This is causing increased
intracranial pressure, which is the reason for the headaches and vomiting
Ji-woo is experiencing."
I paused, giving
her time to process. "Additionally, because there is bleeding within the
tumor, there is a risk of rapid deterioration." Her hand gripped the
child’s hand tighter. But I had to deliver the next sentence. "However...
Fortunately, we found it relatively early." I pointed to the monitor.
"From what we can see, this appears to be the only site of metastasis. It
hasn't spread extensively throughout the entire body."
A tiny spark of
light returned to her eyes. "This means... we still have options
left." In that moment, the room didn't sink entirely into despair. It
remained heavy, uncertain, and frightening—but the door wasn't completely shut.
I looked at the child once more. Ji-woo was still in pain, but the fight wasn't
over. The differential diagnosis was complete. Now, the real war began.
The Prelude to Treatment: Forming the Multidisciplinary Team
A finished
diagnosis means the time for choices has arrived. We were no longer guessing
what it was; we had to decide what to do. That decision carried a weight and
complexity that no single doctor could bear alone. I moved immediately. In
cases like this, time is the most critical variable. Ji-woo’s intracranial
pressure was rising; the tumor was obstructing the ventricle and worsening her
condition by the hour. Hesitation was a danger in itself.
We immediately
convened a Multidisciplinary Team (MDT). Specialists from neurosurgery,
pediatrics, radiation oncology, radiology, and nuclear medicine gathered in one
room. This meeting was not a mere exchange of opinions; it was the gathering of
all available knowledge and experience around a single life. The air in the
conference room was thick with tension. Ji-woo’s CT, MRI, and MIBG scans were
displayed in sequence on the monitors.
The Tactical Briefing: Life vs. Death
The neurosurgery
professor spoke first. "The most urgent issue is the increased
intracranial pressure." His eyes were fixed on the tumor blocking the
ventricle. "If we leave it as is, her consciousness will deteriorate, and
in the worst-case scenario, it could lead to brain herniation." This was
no exaggeration. We weren't just discussing 'cancer treatment'; we were
deciding if we could keep her alive.
The pediatrician
followed. "Her systemic status is still holding. If we intervene quickly,
she is in a condition to withstand surgery and the subsequent treatments."
That sentence became our baseline. Ji-woo was still in the fight.
Radiation
oncology presented the post-operative strategy. "We need a plan to resect
as much as possible, followed by radiation and additional chemotherapy if
necessary. But for now, the surgical approach is the priority." The
conclusion converged into one path. The first goal was clear: Lower the
intracranial pressure and secure a tissue sample. This wasn't a simple surgery.
It was a high-stakes intervention requiring both urgency and extreme precision.
The
Surgical Strategy: Navigating the Core
I looked at the
images again. The tumor was in the frontal horn of the right lateral
ventricle—an anatomically deep location surrounded by dense, vital neural
structures. An error of just a few millimeters could be catastrophic.
The neurosurgery
team began detailing the plan. "We must use stereotactic navigation."
This system tracks the patient’s brain structure in 3D in real-time, acting
like a GPS to guide the surgeon through the invisible paths of the brain.
"We will approach via microsurgery, removing the tumor while minimizing
damage to healthy tissue." A surgical microscope isn't just a magnifying
tool; it provides a precise field of vision that can distinguish between
microscopic vessels and nerve fibers.
"We also
need to be prepared to insert an External Ventricular Drain (EVD) if necessary
to drain CSF and immediately lower the pressure." The meeting became
increasingly concrete. Every possible scenario—the best case and the absolute
worst—was scrutinized. Watching them, I felt it again: medicine is never a solo
battle. Especially with a disease this complex, 'treatment' only exists when
the knowledge of every field merges into one.
The Final Decision: A Terror and a Hope
As the meeting
closed, the final decision was made. Immediate surgery. No delays permitted. I
stood up and took a deep breath. Now, I had to explain this plan to the
guardian. Ji-woo’s mother was still waiting outside the ward, the weight of the
night reflected in her eyes.
I stood before
her. "Mother, the most important thing right now..." As I started to
speak, I realized again that this wasn't just a medical decision. This was a
story about a child’s life and a family’s time. "It's surgery." That
one word was both a terror and a hope.
[Medical
Insight]: Why Intraventricular Metastasis is Dangerous
- Hydrocephalus: The tumor blocks the
flow of cerebrospinal fluid, causing the ventricles to expand and put
pressure on brain tissue.
- Acute
Hemorrhage:
Neuroblastomas are highly vascular and prone to intratumoral bleeding,
which can lead to a rapid drop in consciousness.
- Accessibility: The ventricles are
located in the very center of the brain, meaning there is a high risk of
damaging surrounding normal structures during surgery.
[Medical
Advisory]: In cases of
rare diseases or complex metastatic cancers, it is crucial to choose a hospital
equipped with a 'Multidisciplinary Care' system where experts from various
fields gather. When different perspectives converge, the best treatment
path—previously invisible—finally reveals itself.

Comments
Post a Comment